Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.
Discover
Back to filter
Show all topics (10)
Related topics
Cytek webinar : Evaluating Spectral Cytometry for Immune Profiling in Viral Disease
May 13, 2021
In conventional fluorescence cytometry, each fluorophore in a panel is measured in a...
May 12, 2021
Cancer cells exhibit metabolic...
Introducing ExoFlex - The latest assay for customized EV detection
May 11, 2021
ExoFlex allows users to customize the detection of EVs via any custom antibody. Nanoview...
Cytek Aurora webinar: design of immuno-oncology panels for research and clinical routine
May 11, 2021
During this webinar we will...
Developing tools for multiplex to single EV analysis pipelines
May 10, 2021
Extracellular vesicles (EVs) are lipid spheres released from cells. EVs express proteins...
Single-cell DNA Analysis of a Novel Acute Erythroid Leukemia CRISPR Induced Mouse Model
May 9, 2021
Assessment of precise genetic edits. Analysis of the clonal structure & co-mutations of AEL. Use of CRISPR and...
SARS-CoV-2 detection workflow in wastewater - Analytik Jena and project in Japan
May 8, 2021
In 2020 Analytik Jena real-time PCR thermal cyclers of the qTOWER³ series even supported one of the first SARS-CoV-2...
The impact of environmental Oxygen content on Natural Killer Cell Immunotherapy
May 7, 2021
Natural Killer (NK) cells are being studied in the clinic in a number of settings,...
Rethinking 3D cell culture with IncuCyte: advanced cell cultures from iPSCs and organoids
May 6, 2021
The world is neither flat nor two-dimensional, so why should cell culture be? Traditional...
Build your experiments online with new Spectrum Viewer and SpectroFlo Experiment Builder
May 5, 2021
Explore new capabilities of Cytek's Full Spectrum Viewer and complementary SpectroFlo...
Investigating intracerebral hemorrhage therapeutics
Feb 23, 2017
Neurological outcomes are poor among individuals who experience intracerebral hemorrhage (ICH), a common form of stroke. Up to 50% of patients die within 30 days of ICH and less than one third of survivors ever regain functional independence. Furthermore, there has been little improvement in recovery rate after ICH and no effective treatment strategies are available.
Studies investigating ways to improve recovery rates and treatments can involve the measurement of hemorrhage volume by magnetic resonance imaging (MRI). Researchers at Duke University Medical Center in Durham, US recently used Bruker BioSpin’s 7.0T MRI scanner for this purpose.
Brand profile
